Tet2 Mutations | List of Frontiers open access articles

Original Research

Published on 05 Jan 2026

Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients

in Hematologic Malignancies

Zhuanghui Hao
Jingjing Xia
Sicheng Bian
Miaoke Song
Miao Zhang
Jingyi Feng
Shuo Li
Huichao Wang
Yaofang Zhang
Wanfang Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1730830

1,600 views

Case Report

Published on 10 Dec 2025

Blastic plasmacytoid dendritic cell neoplasm secondary to acute myeloid leukemia with shared mutations in TET2 and DNMT3A: a case report and literature review

in Cancer Immunity and Immunotherapy

Yao Sun
Yingjie Liu
Na Liu
Xiaohui Zhang
Wenrong Huang
Liangding Hu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1656157

1,217 views

Original Research

Published on 23 Aug 2021

Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia

in Hematologic Malignancies

Carlos C. Smith-Díaz
Nicholas J. Magon
Judith L. McKenzie
Mark B. Hampton
Margreet C. M. Vissers
Andrew B. Das

Frontiers in Oncology

doi 10.3389/fonc.2021.709543

16,313 views
17 citations

Brief Research Report

Published on 22 Aug 2025

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

in Molecular and Cellular Oncology

Yang Zhang
Yujiao Luo
Hongling Peng
Yafei Yin
Guangsen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605369

1,492 views

Original Research

Published on 14 Jan 2022

Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma

in Thoracic Oncology

Ying Chen
Xiaoying Cui
Di Wang
Guojie Xia
Minyan Xing
Lei Cheng
Liming Sheng
Xianghui Du

Frontiers in Oncology

doi 10.3389/fonc.2021.664397

5,666 views
13 citations

Original Research

Published on 13 May 2025

Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis

in Hematology

Yi Chen
Zhengjun Wu
Yanxin Chen
Zhengyang Wang
Ruyu Cai
Yong Wu
Jing Zheng

Frontiers in Medicine

doi 10.3389/fmed.2025.1594784

2,825 views
1 citation

Review

Published on 05 Jan 2026

Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies

in Hematology

Rui Zhang
Wei Kou
Tao Wu
Rui Zhou

Frontiers in Medicine

doi 10.3389/fmed.2025.1712877

1,938 views

Case Report

Published on 13 Feb 2026

Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation – a case report

in Cancer Immunity and Immunotherapy

Qing Li
Shishuo Dai
Chenlu Yang
Weiping Liu
Yu Wu

Frontiers in Immunology

doi 10.3389/fimmu.2026.1698958

529 views

Review

Published on 10 Apr 2026

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology

in Atherosclerosis and Vascular Medicine

Hong Wu
Xinyi Meng
Long Li
Chao Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1796328

740 views

Articles

Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients

Blastic plasmacytoid dendritic cell neoplasm secondary to acute myeloid leukemia with shared mutations in TET2 and DNMT3A: a case report and literature review

Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma

Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis

Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies

Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation – a case report

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology